{"url_path":"/sec/ngne/8-k/2026-06-29/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1404644/0001404644-26-000046-index.html","accession_number":"0001404644-26-000046","cik":"0001404644","ticker":"NGNE","issuer_name":"Neurogene Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1404644/0001404644-26-000046-index.html","primary_entity_key":"0001404644","primary_entity_name":"Neurogene Inc."},"word_count":84,"has_tables":true,"body_markdown":"Item 9.01Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNumber\n  Description\n\n99.1  \n[Press Release dated June 29, 2026](ngne_irsf2026datapressrele.htm)\n\n99.2\n[Corporate Presentation dated June 29, 2026](ngne_ngn-401june2026upda.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nNEUROGENE INC.\n\nDate: June 29, 2026By:/s/ Christine Mikail\n\nName: Christine Mikail\n\nTitle: President, Chief Financial Officer"}